NASDAQ · Biotechnology

MGTX (MGTX) Stock

$14.06 -0.92% NASDAQ: MGTX Healthcare

Valuation

MetricValue
Price$14.06
Market Cap$1.30B
P/E Ratio19.70
P/B Ratio6.35
P/S Ratio3.49
EPS (TTM)$-1.42
52-Week High$15.35
52-Week Low$6.62
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE284.38%
ROA19.92%
ROCE54.39%
Gross Margin-130.86%
Operating Margin-130.86%
Net Margin19.87%
Debt/Equity0.52
Current Ratio0.75

Annual Financials (USD)

Metric20212022202320242025
Revenue$38.0M$16.0M$14.0M$33.0M$81.0M
Operating Profit$-73.0M$-116.0M$-137.0M$-164.0M$-106.0M
Net Profit$-80.0M$-130.0M$-84.0M$-148.0M$-114.0M
EPS$-1.80$-2.87$-1.49$-2.12$-1.42
Op Margin-193.0%-730.9%-977.8%-493.4%-130.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$320.0M$318.0M$327.0M$270.0M$244.0M
Total Liabilities$135.0M$200.0M$189.0M$202.0M$250.0M
Cash$138.0M$116.0M$130.0M$104.0M$66.0M
Borrowings$24.0M$92.0M$89.0M$85.0M$89.0M

Latest News

MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last? Zacks · Jul 8, 2026 RBC Capital Adjusts MeiraGTx Price Target to $26 From $25, Maintains Outperform Speculative Risk Rating MT Newswires · Jul 8, 2026 Top Midday Gainers MT Newswires · Jul 7, 2026 MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec) GlobeNewswire · Jul 7, 2026 Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint Insider Monkey · May 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-73.0M$-105.0M$-104.0M$-46.0M
Investing Cash Flow$-117.0M$-90.0M$14.0M$19.0M$-8.0M
Financing Cash Flow$0$-5.0M$-8.0M$-5.0M$-3.0M
Net Cash Flow$-72.0M$-22.0M$15.0M$-25.0M$-37.0M
Free Cash Flow$-66.0M$-118.0M$-126.0M$-109.0M$-50.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.09
EV / EBITDA5.22
FCF Yield0.46%
Quick Ratio3.76
Interest Coverage14.75
Return 1Y42.52%
Return 3Y74.60%
Return 5Y-11.40%

Ownership

Insiders Held17.12%
Institutions Held61.14%
Institutions Float Held73.77%
Institutional HolderSharesReport Date
Sanofi12,197,7372026-03-31
Perceptive Advisors Llc10,326,1032026-03-31
Rubric Capital Management LP7,000,0002026-03-31
Johnson & Johnson6,641,0642026-03-31
Adage Capital Partners GP L.L.C.4,000,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABSI $8.80 -0.45% -11.32 $1.49B 0.00%
ARVN $9.59 +3.34% -6.94 $618.76M 0.00%
ATXSAstria Therapeutics, Inc. $12.58 +0.00% -7.40 $718.13M 0.00%
AVBP $30.51 +1.19% -8.82 $1.42B 0.00%
DNA $7.03 +1.44% -1.30 $459.23M 0.00%

About MGTX

MGTX is led by CEO Alexandria Forbes, employs 375 people, headquartered in US, publicly traded since 2018.

MGTX stock trades at $14.06 with a market capitalization of $1.30B. The stock is valued at a price-to-earnings (P/E) ratio of 19.70, price-to-book of 6.35, price-to-sales of 3.49. Over the past 52 weeks the stock has ranged between $6.62 and $15.35, and currently trades 8.4% below its 52-week high.

On profitability, MGTX generates a return on equity (ROE) of 284.38% — well above the market average, a sign of a high-quality business, return on capital employed of 54.39%, an operating margin of -130.86%, a net profit margin of 19.87%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides